Solventum Q2 Adjusted EPS USD 2.55 Vs. IBES Estimate USD 1.91
SOLV•Q2 results and outlook
Aug. 5 (Reuters) - Solventum Q2 sales were USD 2,209 million vs. the IBES estimate of USD 2,156 million.
- Q2 adjusted EPS: USD 2.55 vs. IBES estimate USD 1.91
- Q2 EPS: USD 0.53
- Q2 net income: USD 92 million
- Outlook: FY organic sales growth 2.5%–3%




